SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Cellular Biomedicine Gr Q1 EPS $(0.600) Down From $(0.510) YoY

Cellular Biomedicine Gr (NASDAQ:CBMG) reported quarterly losses of $(0.600) per share. This is a 17.65 percent decrease over losses of $(0.510) per share from the same period last year.

Benzinga · 05/06/2020 20:50

Cellular Biomedicine Gr (NASDAQ:CBMG) reported quarterly losses of $(0.600) per share. This is a 17.65 percent decrease over losses of $(0.510) per share from the same period last year.